Sopheon PLC
25 July 2001
FOR IMMEDIATE RELEASE 25 July 2001
SOPHEON PLC
Sopheon Announces Establishment of Depositary Receipt Share-Trading Facility
Move Enables U.S. Investors to Trade Sopheon Shares in Over-The-Counter Market
Sopheon plc ('Sopheon') announces that it has established an American
Depositary Receipt (ADR) program for Sopheon's shares currently trading on the
Alternative Investment Market of the London Stock Exchange (LSE). Sponsored by
the Bank of New York, the ADR enables U.S. investors to trade Sopheon shares
in the over-the-counter market by purchasing certificates that represent
ordinary shares of Sopheon stock. ADRs make trading foreign-based securities
easier for U.S. investors through the elimination of many currency exchange,
legal, and foreign-ownership transfer obstacles.
The ADR details are:
* Ratio: 1 ADR = 10 ordinary shares
* Exchange: Nasdaq over-the-counter ('OTC')
* Symbol: SOPEY
* CUSIP: 83577P103
Sopheon Chief Financial Officer Arif Karimjee said:
'Last year's merger with Teltech has given Sopheon important visibility in the
U.S. marketplace and a significant number of U.S. shareholders, including many
of our staff. The establishment of an ADR program will facilitate trading of
Sopheon shares by U.S. investors.'
For further information contact :
Sopheon plc Tel : + 44 (0) 1483-883000
Barry Mence, Chairman
Arif Karimjee, CFO
James MacFarlane, Vice President of Business
Development
Buchanan Communications Tel : + 44 (0)
20-7466-5000
Edward Cowdery
(
Citigate First Financial Tel : + 31 (0) 205-754-080
Barbara Jansen
Note to Editors:
About Sopheon
Sopheon (LSE: SPE), which is listed on the Alternative Investment Market of
the London Stock Exchange, last year merged with Minneapolis-based Teltech
Resource Network Corporation, is a leading international provider of
information and knowledge solutions that enable companies to more efficiently
access internal and external information and turn it into the knowledge to
compete. Sopheon's experience in integrating information process and content
is the foundation for a combination of pre-loaded, industry-specific software
applications, expert services and specialized content. Its comprehensive
solutions can enhance business processes ranging from product development and
customer relationship management to R&D and quality management. Sopheon has
operating bases in the United Kingdom, the Netherlands, Germany and the United
States. Its clients are companies in the life sciences, high tech and
healthcare industry sectors, and include nearly half of the technology-driven
companies on the Fortune 500. For more information, please visit
www.sopheon.com.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.